24小时热门版块排行榜    

查看: 428  |  回复: 1

johncena

木虫 (小有名气)

[求助] 急求usp35版药典中Rivastigmine Tartrate 的质量标准

如题,哪位虫友有pdf的话麻烦发我一份,在目录上查询应该是在p4580和p4581,谢谢!
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

泡泡-211

至尊木虫 (知名作家)

【答案】应助回帖

★ ★ ★
感谢参与,应助指数 +1
johncena: 金币+3, ★★★★★最佳答案, 感谢你的帮助! 2012-09-02 13:24:28
Rivastigmine Tartrate


C14H22N2O2 · C4H6O6 400.42
Ethylmethylcarbamic acid, 3-[(S)-1-(dimethylamino)ethyl]phenyl ester, (2R ,3R )-2,3-dihydroxybutanedioate;     
(S)-3-[1-(Dimethylamino)ethyl]phenyl ethylmethylcarbamate, hydrogen tartrate         [129101-54-8].
Rivastigmine      250.34    [123441-03-2].
DEFINITION
Rivastigmine Tartrate contains NLT 98.0% and NMT 102.0% of the labeled amount of C14H22N2O2 · C4H6O6 , calculated on the anhydrous basis.
IDENTIFICATION
•  A. Infrared Absorption 197K
•  B. The retention time of the major peak of the Sample solution corresponds to that of the System suitability solution, as obtained in the test for Organic Impurities, Procedure 2: Enantiomeric Purity.
ASSAY
•  Procedure
Buffer:  8.6 mg/mL of monobasic ammonium phosphate. Adjust with ammonia solution to a pH of 7.0.
Mobile phase:  Methanol, acetonitrile, and Buffer (15:15:70)
System suitability solution:  0.05 mg/mL each of USP Rivastigmine Related Compound A RS and USP Rivastigmine Related Compound B RS in Mobile phase
Standard solution:  0.2 mg/mL of USP Rivastigmine Tartrate RS in Mobile phase
Sample solution:  0.2 mg/mL of Rivastigmine Tartrate in Mobile phase
Chromatographic system  
(See Chromatography 621 , System Suitability.)
Mode:  LC
Detector:  UV 215 nm
Column:  4.6-mm × 25-cm; 5-μm packing L7
Flow rate:  1.2 mL/min
Injection size:  20 μL
[Note— The flow rate may be adjusted to 1.5 mL/min, if needed, to achieve a recommended retention time of rivastigmine at about 10 min. ]
System suitability  
Samples:  System suitability solution and Standard solution
Suitability requirements  
Resolution:  NLT 1.5 between rivastigmine related compound A and rivastigmine related compound B, System suitability solution
Column efficiency:  NLT 5000 theoretical plates, Standard solution
Tailing factor:  NMT 3.0, Standard solution
Relative standard deviation:  NMT 2.0%, Standard solution
Analysis  
Samples:  Standard solution and Sample solution
Calculate the percentage of C14H22N2O2 · C4H6O6 in the portion of Rivastigmine Tartrate taken:
Result = (rU /rS ) × (CS /CU ) × 100
rU  = = peak response from the Sample solution  
rS  = = peak response from the Standard solution  
CS  = = concentration of the Standard solution (mg/mL)
CU  = = concentration of the Sample solution (mg/mL)

Acceptance criteria:  98.0%–102.0% on the anhydrous basis
IMPURITIES
Inorganic Impurities  
•   Residue on Ignition 281 : NMT 0.1%
•   Heavy Metals, Method II 231 : NMT 20 ppm
Organic Impurities  
•  Procedure 1
Mobile phase and System suitability solution:  Proceed as directed in the Assay.
Standard solution:  1.0 μg/mL of USP Rivastigmine Tartrate RS in Mobile phase
Sample solution:  1.0 mg/mL of Rivastigmine Tartrate in Mobile phase
Chromatographic system:  Proceed as directed in the Assay.
(See Chromatography 621 , System Suitability.)
System suitability  
Samples:  System suitability solution and Standard solution
Suitability requirements  
Resolution:  NLT 1.5 between rivastigmine related compound A and rivastigmine related compound B, System suitability solution
Relative standard deviation:  NMT 10%, Standard solution
Analysis  [Note— The run time is 8 times the retention time of the rivastigmine peak. ]
Samples:  Standard solution and Sample solution
Calculate the percentage of any individual impurity in the portion of Rivastigmine Tartrate taken:
Result = (rU /rS ) × (CS /CU ) × (1/F) × 100
rU  = = peak response for each impurity from the Sample solution  
rS  = = peak response from the Standard solution  
CS  = = concentration of USP Rivastigmine Tartrate RS in the Standard solution (mg/mL)
CU  = = concentration of Rivastigmine Tartrate in the Sample solution (mg/mL)
F = = relative response factor (see Impurity Table 1)

Acceptance criteria  
Individual impurities:  See Impurity Table 1.
Total impurities:  NMT 0.5%
Impurity Table 1
Name Relative
Retention
Time Relative
Response
Factor Acceptance
Criteria,
NMT (%)
Tartrate  0.18 —  Disregard
Phenol impuritya  0.28 1.6 0.3
DPTTAb  0.46 0.83 0.15
Nor impurityc  0.57 1.2 0.15
Rivastigmine  1.0 1.0 —  
Carbamate impurityd  4.1 1.3 0.15
Ether impuritye  6.5 1.4 0.15
Any other impurity —  1.0 0.1
a   (S)-3-[1-(Dimethylamino)ethyl]phenol.
b   (+)-Di-(p-toluoyl)-d-tartaric acid (rivastigmine related compound A).
c   (S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate (rivastigmine related compound B).
d   3-Nitrophenyl ethyl(methyl)carbamate.
e   (S)-N,N-Dimethyl-1-[3-(4-nitrophenoxy)phenyl]ethanamine.  

•  Procedure 2: Enantiomeric Purity
Buffer:  Transfer 1.78 g of dibasic sodium phosphate dihydrate and 1.38 g of monobasic sodium phosphate into a 1000-mL volumetric flask. Dissolve in and dilute with water to volume. Adjust with phosphoric acid to a pH of 6.0.
Mobile phase:  Transfer 20 mL of acetonitrile and 205 μL of N,N-dimethyloctylamine to a 1000-mL volumetric flask, and dilute with Buffer to volume.
Standard solution:  0.1 μg/mL of USP Rivastigmine Tartrate R-Isomer RS in Mobile phase
Sensitivity solution:  0.05 μg/mL of USP Rivastigmine Tartrate R-Isomer RS in Mobile phase, Standard solution
System suitability solution:  100 μg/mL of USP Rivastigmine Tartrate RS and 0.1 μg/mL of USP Rivastigmine Tartrate R-Isomer RS in Mobile phase
Sample solution:  100 μg/mL of Rivastigmine Tartrate in Mobile phase
Chromatographic system  
(See Chromatography 621 , System Suitability.)
Mode:  LC
Detector:  UV 200 nm
Column:  4.0-mm × 10-cm; packing L41
Flow rate:  0.5 mL/min
Injection size:  20 μL
System suitability  
Samples:  Standard solution, Sensitivity solution, and System suitability solution
Suitability requirements  
Resolution:  NLT 0.8 between the enantiomer peaks, System suitability solution
[Note— The elution order is the R-enantiomer, followed by the rivastigmine peak, which is the S-enantiomer. ]
Signal-to-noise ratio:  NLT 10, Sensitivity solution
Relative standard deviation:  NMT 10%, Standard solution
Analysis  
Samples:  Standard solution and Sample solution
Calculate the percentage of the R-enantiomer in the portion of Rivastigmine Tartrate taken:
Result = (rU /rS ) × (CS /CU ) × 100
rU  = = peak response of R-enantiomer from the Sample solution  
rS  = = peak response of R-enantiomer from the Standard solution  
CS  = = concentration of R-enantiomer in the Standard solution (μg/mL)
CU  = = concentration of Rivastigmine Tartrate in the Sample solution (μg/mL)

Acceptance criteria:  NMT 0.3% of the R-enantiomer
SPECIFIC TESTS
•   Water Determination, Method Ia 921 : NMT 0.5%
ADDITIONAL REQUIREMENTS
•  Packaging and Storage: Preserve in tight containers, and store at room temperature.
•   USP Reference Standards 11
USP Rivastigmine Tartrate RS
USP Rivastigmine Related Compound A RS
Di-p-toluoyl-d-(+)-tartaric acid monohydrate.
     C20H20O9          404.37
USP Rivastigmine Related Compound B RS
N,N-Dimethylcarbamic acid-3-[1-(dimethylamino)ethyl]phenyl ester.
     C13H20N2O2          236.32
USP Rivastigmine Tartrate R-Isomer RS
独立的人格,自由的思想
2楼2012-08-31 17:11:47
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 johncena 的主题更新
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[考博] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +3 TxdNP2oT1Q0A 2026-11-21 3/150 2026-11-22 20:16 by AyQg4gRU5coM
[博后之家] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +3 TxdNP2oT1Q0A 2026-11-21 3/150 2026-11-22 19:55 by EFrqTWPNvJJu
[论文投稿] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +3 TxdNP2oT1Q0A 2026-11-21 4/200 2026-11-22 19:44 by 4xQThdVkmqn8
[公派出国] 售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急 +3 TxdNP2oT1Q0A 2026-11-21 3/150 2026-11-22 19:33 by 4xQThdVkmqn8
[论文投稿] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +3 Gt0XhENGW3Q3 2026-11-21 5/250 2026-11-22 18:37 by 4xQThdVkmqn8
[公派出国] 售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急 +4 Gt0XhENGW3Q3 2026-11-21 5/250 2026-11-22 18:16 by 4xQThdVkmqn8
[博后之家] 售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急 +3 YpGmINmR5fp3 2026-11-21 4/200 2026-11-22 18:04 by 4xQThdVkmqn8
[硕博家园] 售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急 +4 YpGmINmR5fp3 2026-11-21 5/250 2026-11-22 17:42 by 4xQThdVkmqn8
[硕博家园] 售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急 +5 K2uSGhxsSAvH 2026-11-21 6/300 2026-11-22 17:21 by 4xQThdVkmqn8
[公派出国] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +7 YLsF7OSIoYU4 2026-11-21 7/350 2026-11-22 16:48 by 4xQThdVkmqn8
[论文投稿] 售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急 +6 Xoz0hXWi9tT1 2026-11-21 7/350 2026-11-22 16:26 by 4xQThdVkmqn8
[考研] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +4 Xoz0hXWi9tT1 2026-11-21 7/350 2026-11-22 16:15 by 4xQThdVkmqn8
[公派出国] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +3 Xoz0hXWi9tT1 2026-11-21 4/200 2026-11-22 16:04 by 4xQThdVkmqn8
[考研] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +3 YpGmINmR5fp3 2026-11-21 4/200 2026-11-22 10:55 by HAlUgI97lcPc
[论文投稿] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +3 YpGmINmR5fp3 2026-11-21 3/150 2026-11-22 10:33 by HAlUgI97lcPc
[论文投稿] 售SCI一区T0P文章,我:8O.55.1.O.54,科目全,可伽急 +5 Xoz0hXWi9tT1 2026-11-21 7/350 2026-11-22 09:16 by HAlUgI97lcPc
[考研] 售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急 +3 Xoz0hXWi9tT1 2026-11-21 3/150 2026-11-22 03:56 by mNjrFMLoQVIW
[材料综合] 憎水剂,表面活性剂 20+3 tan19990622 2026-11-19 3/150 2026-11-21 18:24 by tfang
[教师之家] 售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急 +3 Xoz0hXWi9tT1 2026-11-21 4/200 2026-11-21 15:48 by Gt0XhENGW3Q3
[论文投稿] 食品与机械 编辑C处理稿子时间 10+3 奇妙001 2026-11-19 4/200 2026-11-20 15:02 by tfang
信息提示
请填处理意见